The Board proposes the rule amendment to remove language that is no longer necessary.

 

DEPARTMENT OF HEALTH

Board of Optometry

RULE NO.:RULE TITLE:

64B13-10.001Application for Certification

PURPOSE AND EFFECT: The Board proposes the rule amendment to remove language that is no longer necessary.

SUMMARY: Unnecessary language will be removed.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION:

The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members and the substance of the rule, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary because the rule has no impact on any persons or businesses; and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 456.013, 456.025, 463.005(1), 463.006 FS.

LAW IMPLEMENTED: 463.013, 456.025, 456.0635, 463.002(3)(c), 463.006 FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Dr. Anthony Spivey, Executive Director, Board of Optometry, 4052 Bald Cypress Way, Bin #C07, Tallahassee, FL 32399-3257.

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B13-10.001 Application for Certification.

To be certified to administer and prescribe topical ocular pharmaceutical agents a licensed practitioner must be a Florida licensed Certified Optometrist submit a completed application, DH/MQA 1128 (07/19), “Application for Licensure As Certified Optometrist,” hereby incorporated by reference, provided by the Board or at http://www.Floridasoptometry.gov, or http://www.flrules.org/Gateway/reference.asp?No=Ref-11407; remit the application fee for certification specified in subsection 64B13-6.001(5), F.A.C.; and demonstrate compliance with the following requirements:

(1) through (3) No change.

Rulemaking Authority 456.013, 456.025, 463.005(1), 463.006 FS. Law Implemented 463.013, 456.025, 456.0635, 463.002(3)(c), 463.006 FS. History–New 11-20-86, Amended 7-6-88, 3-16-89, Formerly 21Q-10.001, 61F8-10.001, Amended 10-4-94, Formerly 59V-10.001, Amended 7-21-11, 2-27-14, 7-31-14, 12-4-16, 11-4-18, 1-2-20,                          .

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Optometry

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Optometry

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: July 15, 2020

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: August 19, 2020